Inventor · disambiguated record
George P. Tuszynski
Also filed as: TUSZYNSKI GEORGE · TUSZYNSKI GEORGE P · TUSZYNSKI GEORGE PAUL
22 granted patents·6 pending applications·268 citations·filing 1990–2020
95Inventor score
Files withGRACE W R & CO9CHANG FRANK N3PHILADELPHIA HEALTH & EDUCATIO3PROPLEX TECH LLC3INKINE PHARMACEUTICAL COMPANY2
Top patents by PatentIndex Score
28 records- 0183US6380161B1Compositions for treating chemotherapy-resistant tumor cells and targeted chemotherapy compositionsINKINE PHARMACEUTICAL COMPANY·Filed 2000·Granted Apr 30, 2002·15 cites·15 claims
- 0280US5506208AMethod for using synthetic analogs of thrombospondin for inhibiting angiogenesis activityGRACE W R & CO·Filed 1995·Granted Apr 9, 1996·32 cites·10 claims
- 0375US8420333B2G-protein coupled receptor-associated sorting protein 1 as a cancer biomarkerCHANG FRANK N·Filed 2012·Granted Apr 16, 2013·2 cites·15 claims
- 0475US5190920AMethod for using synthetic analogs of thrombospondin for inhibiting metastasis activityGRACE W R & CO·Filed 1990·Granted Mar 2, 1993·35 cites·8 claims
- 0573US5190918APeptide fragments and analogs of thrombospondin and methods of useGRACE W R & CO·Filed 1990·Granted Mar 2, 1993·40 cites·7 claims
- 0671US8980269B2G-protein coupled receptor-associated sorting protein 1 as a cancer biomarkerUNIV TEMPLE·Filed 2013·Granted Mar 17, 2015·1 cites·5 claims
- 0770US8901083B2Administration of angiocidin for the treatment of leukemiaTUSZYNSKI GEORGE P·Filed 2009·Granted Dec 2, 2014·1 cites·13 claims
- 0869US7625868B2Methods and compositions for inhibiting angiogenesisPHILADELPHIA HEALTH & EDUCATIO·Filed 2007·Granted Dec 1, 2009·3 cites·1 claims
- 0969US5155038AUse of thrombospondin to promote wound healingGRACE W R & CO·Filed 1990·Granted Oct 13, 1992·22 cites·4 claims
- 1067US5200397AUse of peptide analogs of thrombospondin for the inhibition of angiogenic activityGRACE W R & CO·Filed 1991·Granted Apr 6, 1993·23 cites·4 claims
- 1165US5840692APeptide fragments and analogs of thrombospondinALLEGHENY UNIVERSITY OF THE HE·Filed 1995·Granted Nov 24, 1998·28 cites·17 claims
- 1264US9140704B2Serum markers associated with early and other stages of breast cancerCHANG FRANK N·Filed 2010·Granted Sep 22, 2015·1 cites·13 claims
- 1360US9526758B2Administration of angiocidin for arresting the growth of a tumor cellTEMPLE UNIV OF THE COMMONWEALTH OF HIGHER EDUCATION·Filed 2014·Granted Dec 27, 2016·0 cites·7 claims
- 1458US5654277APeptides having thrombospondin-like activity and their therapeutic useGRACE W R & CO·Filed 1995·Granted Aug 5, 1997·16 cites·5 claims
- 1556US6339062B1Retroinverso polypeptides that mimic or inhibit thrombospondin activityINKINE PHARMACEUTICAL COMPANY·Filed 1998·Granted Jan 15, 2002·19 cites·10 claims
- 1654US2017128525A1Administration of Angiocidin for the Treatment of CancerTEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2016·Application pending·0 cites
- 1753US6239110B1Synthetic analogs of thrombospondin and therapeutic use thereofGRACE W R & CO·Filed 1995·Granted May 29, 2001·17 cites·9 claims
- 1848US9903871B2Stabilized peptide fragments from nucleoredoxin X1 and uses thereofUNIV TEMPLE·Filed 2015·Granted Feb 27, 2018·0 cites·8 claims
- 1948US5648461ASynthetic analogs of thrombospondin and therapeutic use thereofGRACE W R & CO·Filed 1995·Granted Jul 15, 1997·8 cites·1 claims
- 2044US8333880B2Method for detecting disease markersCHANG FRANK N·Filed 2008·Granted Dec 18, 2012·0 cites·32 claims
- 2143US12110340B2Binding proteins and chimeric antigen receptor T cells targeting GASP-1 granules and uses thereofPROPLEX TECH LLC·Filed 2019·Granted Oct 8, 2024·0 cites·45 claims
- 2243US2003171298A1Retroinverso polypeptides that mimic or inhibit thrombospondinINKINE PHARMACEUTICALS MCP HAH·Filed 2001·Application pending·0 cites
- 2342US7160858B2Methods and compositions for inhibiting angiogenesisPHILADELPHIA HEALTH & EDUCATIO·Filed 2001·Granted Jan 9, 2007·0 cites·4 claims
- 2441US2017174734A1DR6 Receptor Mediates the Leukemia Differentiation Activity of Angiocidin: A Potent Anti-Tumor PeptideTEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2015·Application pending·0 cites
- 2541US2003180295A1Angiocidin: a Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptorPHILADELPHIA HEALTH & EDUCATIO·Filed 2002·Application pending·0 cites
- 2640US5367059ACys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptorGRACE W R & CO·Filed 1992·Granted Nov 22, 1994·5 cites·4 claims
- 2738US2020225235A1Sensitive detection of g-protein coupled receptor-associated sorting protein 1 (gasp-1), gasp-1 microvesicles, and gasp-1 exosomesPROPLEX TECH LLC·Filed 2020·Application pending·0 cites
- 2835US2019195881A1Sensitive detection of g-protein coupled receptor-associated sorting protein 1 (gasp-1), gasp-1 microvesicles, and gasp-1 exosomesPROPLEX TECH LLC·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →